Crystal Roger Insider Trades

Insider Trading History

Track insider trading activity for Crystal Roger. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mind Medicine
Mind Medicine MNMD
Director
Holding Value $1.56M 75,187 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$549k 75,187 shares
$7.30
$20.69
Definium Therapeutics
Definium Therapeutics DFTX
Director
Holding Value $1.77M 75,187 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$23.59
Definium Therapeutics
Definium Therapeutics DFTX
Director
Holding Value $389k 16,506 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$23.59
Mind Medicine
Mind Medicine MNMD
Director
Holding Value $342k 16,506 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 16,506 shares
$7.25
$20.69
Mind Medicine
Mind Medicine MNMD
Director
Holding Value $564k 27,267 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.3k 19,203 shares
$3.61
$20.69
Definium Therapeutics
Definium Therapeutics DFTX
Director
Holding Value $643k 27,267 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$23.59
Definium Therapeutics
Definium Therapeutics DFTX
Director
Holding Value $463k 19,623 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$23.59
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.1M 150,000 shares
$20.65
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$133k 6,667 shares
$20.00
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $783k 37,901 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$749k 37,438 shares
$20.00
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$563k 27,250 shares
$20.65
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$102k 5,100 shares
$20.00
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$516k 25,000 shares
$20.65
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $138k 6,667 shares
Last Trade
Mar 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$138k 6,667 shares
$20.65
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$645k 31,250 shares
$20.65
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$273k 13,200 shares
$20.65
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.74M 375,000 shares
$20.65
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
10% owner, Chief Executive Officer
Holding Value $1.56M 75,339 shares
Last Trade
Jan 27, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.5k 1,358 shares
$20.26
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Chief Executive Officer
Holding Value $1.58M 76,697 shares
Last Trade
Jan 09, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$23.9k 1,183 shares
$20.20
$20.65
Opiant Pharmaceuticals
Opiant Pharmaceuticals OPNT
Chief Executive Officer
Holding Value $1.61M 77,880 shares
Last Trade
Jan 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$102k 5,029 shares
$20.20
$20.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up